Drug Type Small molecule drug |
Synonyms AG 86893 |
Target |
Action inhibitors |
Mechanism RTK inhibitors(Receptor protein-tyrosine kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hyperemia | Phase 2 | Australia | 11 Oct 2018 | |
| Pterygium | Phase 2 | Australia | 11 Oct 2018 |
Phase 2 | 64 | Vehicle Eye Drops (Vehicle Eye Drops) | igmxfaywaa(foyfbruaqg) = uqvmwjefrg hzbhnhxdgn (gpacdqaoew, 0.120) View more | - | 06 Nov 2020 | ||
(0.1% AG-86893 Eye Drops) | igmxfaywaa(foyfbruaqg) = muassihcoh hzbhnhxdgn (gpacdqaoew, 0.109) View more |





